SHEA GUIDELINES Bundle (free trial)

Prevention of SSIs

SHEA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1524015

Contents of this Issue

Navigation

Page 11 of 11

1258 Upsala Rd Sanford, FL 32771 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2023 All rights reserved SHEASSI09232b Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. Abbreviations CDC, Centers for Disease Control and Prevention; CHG, chlorhexidine gluconate; CMS, Centers for Medicare and Medicaid Services; CRNA, certified registered nurse anesthetists; HAI, healthcare-associated infection; HICPAC, Healthcare Infection Control Practices Advisory Committee; IPC, infection prevention and control; NHSN, National Healthcare Safety Network; SIR, standardized infection ratio; SSI, surgical site infection Source Calderwood MS, Anderson DJ, Bratzler DW, Dellinger EP, Garcia-Houchins S, Maragakis LL, Nyquist A-C, Perkins KM, Preas MA, Saiman L, Schaffzin JK, Schweizer M, Yokoe DS, Kaye KS. Strategies to prevent surgical site infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023;44(5):695–720. doi:10.1017/ice.2023.67. Quality of Evidence a Category Definition H = High Highly confident that the true effect lies close to that of the estimated size and direction of the effect, for example, when there are a wide range of studies with no major limitations, there is little variation between studies, and the summary estimate has a narrow confidence interval. M = Moderate e true effect is likely to be close to the estimated size and direction of the effect, but there is a possibility that it is substantially different, for example, when there are only a few studies and some have limitations but not major flaws, there is some variation between studies, or the confidence interval of the summary estimate is wide. L = Low e true effect may be substantially different from the estimated size and direction of the effect, for example, when supporting studies have major flaws, there is important variation between studies, the confidence interval of the summary estimate is very wide, or there are no rigorous studies. a Based on the CDC Healthcare Infection Control Practices Advisory Committee (HICPAC) "Update to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee Recommendations Categorization Scheme for Infection Control and Prevention Guideline Recommendations" (October 2019), the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE), and the Canadian Task Force on Preventive Health Care.

Articles in this issue

Links on this page

Archives of this issue

view archives of SHEA GUIDELINES Bundle (free trial) - Prevention of SSIs